We are live on ! Find out more
ADMA icon

ADMA Biologics
ADMA

90 hedge funds and large institutions have $67.7M invested in ADMA Biologics in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 35 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

6.57% less ownership

Funds ownership: 40.03% → 33.46% (-6.6%)

14% less funds holding

Funds holding: 105 → 90 (-15)

21% less capital invested

Capital invested by funds: $85.4M → $67.7M (-$17.7M)

43% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 35

47% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 32

80% less call options, than puts

Call options by funds: $712K | Put options by funds: $3.49M

Holders
90
Holders Change
-15
Holders Change %
-14.29%
% of All Funds
1.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
20
Reduced
35
Closed
32
Calls
$712K
Puts
$3.49M
Net Calls
-$2.77M
Net Calls Change
-$513K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.57M
2
Millennium Management
Millennium Management
New York
+$1.76M
3
CC
Clearline Capital
New York
+$1.01M
4
GCP
GSA Capital Partners
United Kingdom
+$548K
5
E
Ergoteles
New York
+$527K

Top Sellers

1
BlackRock
BlackRock
New York
-$6.29M
2
N
Nuveen
North Carolina
-$1.5M
3
MS
Maven Securities
Jersey
-$1.32M
4
State Street
State Street
Massachusetts
-$1.05M
5
Northern Trust
Northern Trust
Illinois
-$874K
Name Holding Trade Value Shares
Change 		Change in
Stake
Los Angeles Capital Management
51
Los Angeles Capital Management
California
$59K -$3.69K -2,100 -5%
HSBC Holdings
52
HSBC Holdings
United Kingdom
$53K +$26 +15 +0%
Commonwealth Equity Services
53
Commonwealth Equity Services
Massachusetts
$48K -$35.8K -20,344 -40%
HP
54
Hikari Power
Japan
$48K – – –
XT
55
XTX Topco
Cayman Islands
$40K +$43.8K +24,881 New
Principal Financial Group
56
Principal Financial Group
Iowa
$35K -$596K -338,684 -94%
SWP
57
Stratos Wealth Partners
Ohio
$32K – – –
EAM
58
Eagle Asset Management
Florida
$29K – – –
YIH
59
Y-Intercept (HK)
Hong Kong
$27K +$29.3K +16,656 New
Osaic Holdings
60
Osaic Holdings
Arizona
$23K -$18.2K -10,366 -43%
JIP
61
Jaffetilchin Investment Partners
Florida
$23K – – –
Wells Fargo
62
Wells Fargo
California
$21K -$36.3K -20,630 -61%
JGC
63
J. Goldman & Co
New York
$19K -$52.8K -30,000 -71%
SWMP
64
Signature Wealth Management Partners
New Jersey
$17K – – –
AGM
65
Alpine Global Management
New York
$17K +$18.7K +10,645 New
CPO
66
Cerity Partners OCIO
New York
$16K +$17.6K +10,000 New
Royal Bank of Canada
67
Royal Bank of Canada
Ontario, Canada
$11K -$5.63K -3,203 -31%
Citigroup
68
Citigroup
New York
$9K +$1.4K +795 +18%
UBS Group
69
UBS Group
Switzerland
$8K -$27.2K -15,438 -76%
BC
70
Burleson & Co
California
$8K – – –
SPIA
71
Steward Partners Investment Advisory
New York
$6K – – –
CFD
72
Creative Financial Designs
Indiana
$3K – – –
PMFA
73
Plante Moran Financial Advisors
Michigan
$3K – – –
Rockefeller Capital Management
74
Rockefeller Capital Management
New York
$3K – – –
BNP Paribas Financial Markets
75
BNP Paribas Financial Markets
France
$2.52K -$14.5K -8,214 -84%
1 2
3
4 5

ADMA Hedge Fund Activity: Q2 2021 in Review

90 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in ADMA Biologics (ADMA) for Q2 2021, worth a combined $67.7M — down 21% from $85.4M a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of ADMA and 17 opened new positions — a net loss of 15 holders — while 35 trimmed existing stakes and 20 added.

The largest buyer was Vanguard Group, adding an estimated $2.57M. The largest seller was BlackRock, cutting an estimated $6.29M.

  • 90 institutional investors held ADMA Biologics (ADMA) as of Q2 2021, down from 105 in Q1 2021.
  • Funds reported $67.7M of ADMA Biologics stock for Q2 2021, down 21% quarter-over-quarter.
  • 17 funds opened new ADMA Biologics positions in Q2 2021 and 32 closed out, a net change of -15 holders.
  • The largest ADMA Biologics buyer in Q2 2021 was Vanguard Group, an estimated $2.57M added.
  • The largest ADMA Biologics seller in Q2 2021 was BlackRock, an estimated $6.29M sold.

Based on aggregated 13F filings for Q2 2021.